NCT00408564View on ClinicalTrials.gov

Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Pancreatic Cancer
Interventions
BIOLOGICAL

cetuximab

DRUG

capecitabine

DRUG

oxaliplatin

PROCEDURE

conventional surgery

RADIATION

radiation therapy

DRUG

Gemcitabine

Trial Locations (1)

29425

Hollings Cancer Center at Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT00408564 - Cetuximab, Gemcitabine, and Oxaliplatin Followed By Surgery or External-Beam Radiation Therapy and Capecitabine in Treating Patients With Locally Advanced, Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter